Common synonymous variants in ABCA4 are protective for chloroquine induced maculopathy (toxic maculopathy)
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Chloroquine (CQ) and hydroxychloroquine (HCQ) are used to treat auto-immune related diseases such as rheumatoid arthritis (RA) or systemic lupus erythematosus. Both drugs however can cause retinal toxicity eventually leading to irreversible maculopathy and retinopathy. Established risk factors are duration and dosage of treatment while the involvement of genetic factors contributing to toxic maculopathy is largely unclear. To address the latter issue, this study aimed to expand on earlier efforts by (1) evaluating risk-altering variants known to be associated with age-related macular degeneration (AMD), a frequent maculopathy in individuals over 55 years of age, and (2) determining the contribution of genetic variants in the coding sequence of the ABCA4 gene. METHODS: The ABCA4 gene was analyzed by deep sequencing technology using a personal genome machine (Ion Torrent) with 200 bp read length. Assessment of AMD variants was done by restriction enzyme digestion of PCR products and TaqMan SNP genotyping. Effect sizes, p-values and confidence intervals of common variants were evaluated by logistic regression (Firth's bias corrected). To account for multiple testing, p-values were adjusted according to the false discovery rate. RESULTS: We found no effects of known AMD-associated variants on the risk of toxic maculopathy. In contrast, we report a statistically significant association of common variants in the ABCA4 gene with retinal disease, assessed by a score-based variance-component test (PSKAT = 0.0055). This association remained significant after adjustment for environmental factors like age and duration of medication and was driven by three common variants in ABCA4 (c.5682G > C, c.5814A > G, c.5844A > G), all conferring a reduced risk for toxic maculopathy. CONCLUSIONS: Our findings demonstrate that minor alleles of common genetic variants in ABCA4 significantly reduce susceptibility to develop toxic maculopathy under CQ treatment. A refined risk profile based on genetic and environmental factors may have implications for revised recommendations in CQ as well as HCQ treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias reduction of maximum likelihood estimates
FIRTH, D. (1993) · Biometrika · doi:10.1093/biomet/80.1.27 · Cited by 5,035
Allikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435 · cited 1×
“One study found that two out of eight patients with toxic maculopathy carried monoallelic mutations in ABCA4 [8], a gene in which mutations have been associated with autosomal recessive Stargardt disease [9] and the genetically complex age-related macular degeneration [10,11].”
BackgroundBrest, P., Lapaquette, P., Souidi, M., Lebrigand, K., Cesaro, A., Vouret-Craviari, V., Mari, B., Barbry, P., Mosnier, J.-F., Hébuterne, X., et al. (2011) · Nature Genetics · doi:10.1038/ng.762 · Cited by 563 · cited 1×
“Although synonymous variants are commonly regarded as benign in their effects towards disease, they have the potential to affect RNA stability and RNA splicing and can influence the rate of protein translation and thus protein conformation [26-29].”
BackgroundRadu, R. A., Yuan, Q., Hu, J., Peng, J. H., Lloyd, M., Nusinowitz, S., Bok, D., & Travis, G. H. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1470 · Cited by 188 · cited 14×
“Logistic regression was used to evaluate the effect size, p-values and confidence intervals of common genetic variants in ABCA4 as well as AMD associated variants.”
BackgroundInfluentialChloroquine causes lysosomal dysfunction in neural retina and RPE: implications for retinopathy
Mahon, G. J., Anderson, H. R., Gardiner, T. A., McFarlane, S., Archer, D. B., & Stitt, A. W. (2004) · Current Eye Research · doi:10.1076/ceyr.28.4.277.27835 · Cited by 108
Cited by
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
Marmor, M. F., Kellner, U., Lai, T. Y. Y., Melles, R. B., & Mieler, W. F. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.01.058 · Cited by 1,164
Hydroxychloroquine retinopathy
Yusuf, I. H., Sharma, S., Luqmani, R., & Downes, S. M. (2017) · Eye · doi:10.1038/eye.2016.298 · Cited by 271
Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy
Petri, M., Elkhalifa, M., Li, J., Magder, L. S., & Goldman, D. W. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41121 · Cited by 143
Metadata
- Authors
- Grassmann, F., Bergholz, R., Mändl, J., Jägle, H., Ruether, K., & Weber, B. H.
- Venue
- BMC Ophthalmology
- Published
- 2015-03-06
- Volume
- 15
- Issue
- 1
- Pages
- 18-18
- ISSN
- 1471-2415 (ISSN-L)
- OpenAlex
- W2116072674
- Cited by
- 48
- References
- 5
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Common synonymous variants in ABCA4 are protective for chloroquine induced maculopathy (toxic maculopathy). https://app.cochat.ai/papers/10.1186/s12886-015-0008-0
- The paper
- Grassmann, F., Bergholz, R., Mändl, J., Jägle, H., Ruether, K., & Weber, B. H. (2015). Common synonymous variants in ABCA4 are protective for chloroquine induced maculopathy (toxic maculopathy). BMC Ophthalmology. https://doi.org/10.1186/s12886-015-0008-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.